Cheap CBD vs. Good CBD – How Not to Get Fooled 2026

Hemp oils, gummies, and capsules costing 40 PLN next to products priced at 250 PLN are currently fueling the hottest debate in the Polish CBD market. A staggering 69% of the 84 products tested by the Bonn-Miller, Loflin, and Russo team from Penn State had labels inconsistent with the actual CBD content (JAMA, 2017). A consumer without knowledge of COA, extraction, and the true price per milligram often ends up buying air.

This guide does not demonize cheap products. Instead, it shows how to distinguish a fair deal from marketing fiction, and why the percentage on the bottle says less than the number of milligrams of CBD per PLN. We cite studies from JAMA, FDA warning letters, FTC decisions, EFSA opinions, UOKiK reports, and GIS recalls, which together create a picture of a market full of cognitive traps.

You will learn how to distinguish an isolate masquerading as broad spectrum from a true extract, when MCT is a carrier and when it is a filler, and how anchoring works on the price list. We will show 11 red flags, a practical comparison table, and a checklist before purchase. Goal: an informed choice based on data, not on a banner "minus 70% today only."

KEY FINDINGS
– The price per milligram of CBD, not the percentage on the bottle, is the only true measure of value. The average cost of 1 mg of CBD in products with COA testing ranges from 0.09-0.18 PLN (Project CBD, 2023).
– In a 2017 JAMA study, 69% of 84 tested CBD products had labels that did not match their contents, and 21% contained detectable THC despite claiming „0% THC” (Bonn-Miller et al., JAMA, 2017).
– Lack of a COA for the current batch is the number one red flag, highlighted in FDA warning letters since 2015 (FDA, 2024).
– Isolate sold as full spectrum is a common scam. About 30% of products labeled as full spectrum turn out to be isolates in tests (Project CBD, 2023).
– MCT is an acceptable carrier if its proportion and role are clearly stated on the label.

What is the difference between cheap CBD and good CBD?

Cheap CBD and good CBD differ primarily in transparency and the quality of the raw material. In an audit of 84 products from 2017, only 31% had labels consistent with the actual cannabinoid content (JAMA, 2017). This shows that the promise on the packaging often has little to do with what you are actually buying.

A good product has a clear pedigree. The hemp comes from certified EU farms, extraction is done using supercritical CO2, and each batch has an independent COA available via QR code. The cheaper equivalent often remains silent on key issues: where the raw material comes from, what extraction method is used, and what contaminants may be present.

Price matters, but it is not the only variable. An expensive oil with an impressive label and a celebrity ambassador may have a worse COA than a mid-range product from a Polish manufacturer. What counts is the ratio of milligrams of CBD to PLN, plus real evidence of quality in the form of documents, not advertising slogans.

The three most common differences in practice

Raw material: good CBD comes from industrial hemp (Cannabis sativa L.) grown without pesticides, from organic farming or controlled EU plantations. Cheap CBD often relies on raw materials from less regulated markets, where control over heavy metals and pesticides is weaker. Hemp is a bioaccumulative plant, meaning it absorbs contaminants from the soil (EFSA, 2022).

Extraction: the gold standard is supercritical CO2. It yields a pure extract without solvent residues. Cheaper methods, such as oil maceration or ethanol without thorough evaporation, may leave trace residues. The COA should include a test for residual solvents if a method other than CO2 was used.

Testing: a good manufacturer publishes COA for each batch. Inside, you will find the testing date, batch number, list of cannabinoids (CBD, CBDA, CBG, CBN, THC), terpenes, heavy metals, pesticides, and microorganisms. A cheap manufacturer most often publishes either an old COA for all batches or does not publish one at all.

Price per mg as the only true measure of value

The price per milligram of CBD is the only indicator that allows for fair comparisons of products from different brands. In a review of the Polish market from 2023, the average price of 1 mg of CBD in broad spectrum oils with COA certificates ranged from 0.09 to 0.18 PLN (Project CBD, 2023). A price below 0.05 PLN per mg should raise a red flag.

Counting is simple. Take the price of the bottle, divide it by the total number of milligrams of CBD in the package. A 10 ml bottle containing 10% CBD has 1000 mg of pure cannabinoid. An oil for 99 PLN comes out to 0.099 PLN per mg. An oil for 49 PLN with a declaration of 1000 mg comes out to 0.049 PLN per mg, which is noticeably below market.

A low price per mg does not always mean fraud. Sometimes it is an isolate (cheaper to produce), sometimes a competitive brand reducing margins, and sometimes a batch with an incorrect label. JAMA showed in 2017 that 26% of products contained less CBD than declared, sometimes even 50% less (JAMA, 2017).

Table: indicative prices per mg on the market 2026

Concentration	Mg CBD	Market price	Price per 1 mg CBD
5%	500 mg / 10 ml	76-170 PLN	0.15-0.34 PLN
10%	1000 mg / 10 ml	99-250 PLN	0.10-0.25 PLN
15%	1500 mg / 10 ml	180-340 PLN	0.12-0.23 PLN
20%	2000 mg / 10 ml	260-400 PLN	0.13-0.20 PLN

As you can see, the price per 1 mg in concentrations of 5%-20% is converging when we talk about products with COA testing. The 5% offer for 39 PLN advertised as „organic full spectrum” is worth double-checking. It is either an isolate or a label that does not match the content.

Percentage trap and what really counts

Sellers exploit the fact that customers compare percentages instead of milligrams. An oil „20% in a 5 ml bottle” contains 1000 mg of CBD, which is the same as „10% in a 10 ml bottle”. The price of the first can be higher despite identical value. Always check the bottle volume next to the concentration.

The situation complicates with volumes of 30 ml, 50 ml, and 100 ml. Hemp shots, balms, and hemp cosmetics often have low percentages of CBD with large volumes. An oil with 0.5% in 100 ml contains 500 mg of CBD, which at a price of 90 PLN gives 0.18 PLN per mg. Here, the form of use already affects the real value.

JAMA 2017: why are 70% of labels inaccurate?

A study by Marcel Bonn-Miller's team from Penn State and ICCI published in JAMA in November 2017 examined 84 CBD products purchased online from 31 companies. A staggering 69% had labels inconsistent with the actual CBD content, 26% had less CBD than declared, and 43% had more, which is not a good result (JAMA, 2017).

Why does this happen? Manufacturers often use cheap raw materials with unstable cannabinoid content, do not standardize final formulations, or deliberately inflate declarations to compete on the shelf. The lack of rigorous regulatory oversight in the supplement segment further facilitates such practices.

Worse still, JAMA reported detectable THC in 21% of products, despite claims of „THC-free”. For individuals tested for drugs at work (professional drivers, athletes, law enforcement), this is a very serious issue. Trusting a label without a COA is simply naive.

In the 2017 JAMA study, 69% of the 84 tested CBD products had labels inconsistent with cannabinoid content, and 21% contained detectable THC despite claims of its absence (Bonn-Miller et al., JAMA, 2017). This study remains a benchmark for CBD market regulators worldwide.

What has changed since 2017?

The situation has improved, but not dramatically. Later studies, including Gurley's work from the University of Mississippi in 2020, showed about 40-50% of products with incorrect labels, which is still worryingly high. The FDA sent over 200 warning letters to companies selling CBD with false health claims and inconsistent content from 2015 to 2024 (FDA, 2024).

In Poland, GIS recalled 14 CBD products from the market in 2024 for inconsistencies between declarations and actual THC or CBD content (GIS, 2024). This shows that the problem still exists, although oversight is tightening. UOKiK is simultaneously pursuing deceptive pricing practices based on the Omnibus directive.

Lack of COA: why is lack of transparency a red flag?

COA (Certificate of Analysis) is an analytical document from an independent, accredited laboratory that confirms the composition of a given batch of the product. The FDA in warning letters from 2015-2024 cites lack of COA as one of the most common grounds for legal action against CBD sellers (FDA, 2024). Without COA, you are buying by smell, literally.

A good COA contains nine key elements. Batch number and production date. Name of the laboratory and its accreditation (most often ISO 17025). List of cannabinoids with exact amounts in mg/g or percentages. Terpene profile. Heavy metal test (lead, cadmium, arsenic, mercury). Pesticide test. Microorganism test (E. coli, salmonella, yeast, mold). Residual solvent test. Date of testing.

Red flag: the manufacturer shows a „certificate” without numerical results, just the lab logo and the word „OK”. This means nothing. A full-value COA has an HPLC or GC-MS chart, tables with values, and often an internal lab protocol. A scannable QR code on the packaging leading to the COA for that batch is an industry standard.

How to read a COA step by step

Start with the batch number and date. The number should match the one on the packaging. The testing date should not be older than 6-12 months. Then check the cannabinoid section. Look for CBD, CBDA, CBG, CBN, THC. The sum of cannabinoids in a broad spectrum product should match the declared mg on the bottle, with a deviation of no more than 10-15%.

The contaminants section is equally important. Lead, cadmium, mercury, arsenic should be below the limit of detection or within EU norms for supplements. Pesticides: the most commonly tested are on the EPA list with 70 substances. Microorganisms: E. coli, salmonella, mold, yeast should be absent or below threshold.

The terpene profile is optional, but it should be published in broad and full spectrum products. The absence of terpenes in the COA alongside claims of „full cannabis aroma” suggests that it is indeed an isolate with added flavor.

Isolate masquerading as full spectrum: how to recognize a scam?

An isolate sold as full spectrum is a classic marketing ploy. Project CBD in its 2023 analysis showed that about 30% of products labeled as full spectrum in independent tests turn out to be isolates with added cannabis flavor (Project CBD, 2023). The difference in production cost is 50-70% in favor of the isolate.

Isolate is pure CBD (>99%) without other cannabinoids and terpenes. It is produced through chromatographic separation from the raw material. The raw material for the isolate is cheaper because it does not require maintaining a phytochemical profile. The manufacturer has the isolate at 30-40% of the cost of full extract but sells it with a full spectrum margin.

Without COA, you won't notice this difference. Flavor and aroma can be faked with flavoring, the color of the oil depends on the carrier and extraction. Only a laboratory result gives certainty, where next to CBD you see CBDA, CBG, CBN, CBC, terpenes. In an isolate, these fields are absent or at the level of detection noise.

Why does full spectrum cost more?

Full spectrum requires gentler extraction to preserve the entire cannabinoid and terpene matrix. The raw material must be of higher quality, as it inherits its full phytochemical profile. CO2 extraction with precise temperature and pressure control costs 2-3 times more than simple ethanol extraction or oil maceration.

The entourage effect, described by Russo and Mechoulam in 2011, means that a full profile of cannabinoids provides stronger effects per milligram of CBD than an isolate. This is real value for the user, but requires proof in the form of COA. Without it, you are paying for a slogan, not for a substance.

Project CBD in 2023 estimated that about 30% of products labeled as full spectrum in independent laboratory tests turn out to be isolates with added cannabis flavor, due to even a 70% reduction in production costs compared to true extract (Project CBD, 2023). This is why COA for each batch is the only verification tool.

MCT as a carrier or a scam?

MCT oil (medium-chain triglycerides) is an acceptable and often even desired carrier for CBD. MCT fats increase the oral bioavailability of cannabinoids by 3-5 times compared to other oils (Frontiers in Pharmacology, 2020). The problem only arises when its share in the product is hidden.

Standard CBD oil 10% is 1 g of extract plus 9 g of carrier oil (most often MCT, sometimes hemp seed oil). This is basic math. 90% of the formulation is the carrier, which has a physiological role in transporting cannabinoids into the bloodstream. The mere fact that the product is „mainly MCT” does not make it a fraud.

Fraud begins when the manufacturer hides the composition, uses ambiguous phrases like „hemp oil” (is it extract or seed oil?), or sells a product with 95% MCT plus 5% extract claiming 1500 mg of CBD with a real content of 200 mg. The INCI label should clearly indicate both ingredients.

Hemp seed oil vs MCT oil vs CBD extract

Hemp seed oil (Cannabis Sativa Seed Oil) is a food product extracted from seeds. It contains omega-3 and omega-6 fatty acids and vitamin E, but practically no CBD. Sold as „CBD hemp oil” it is a semantic mistake or a deliberate misrepresentation.

MCT oil is a refined fat from coconut or palm oil, consisting mainly of caprylic and capric acid. It is flavor-neutral, chemically stable, and promotes the absorption of lipophilic substances like CBD. This is why it dominates as a carrier in cannabinoid products.

CBD extract is the result of extraction from cannabis, containing actual cannabinoids. It should be listed separately in the ingredient list, most often as „Cannabidiol” or „Cannabis Sativa Flower/Leaf Extract”. Its absence on the label next to the term „CBD oil” is a red flag.

Anchoring and fake promotions: how does price psychology work?

Anchoring (the anchoring effect), described by Kahneman and Tversky in 1974, is a manipulation technique that uses the first number given as a reference point. Since 2023, UOKiK has been enforcing the Omnibus directive, which requires stating the lowest price from the 30 days prior to the promotion (Office of Competition and Consumer Protection, 2024). Nevertheless, many CBD sellers still inflate the base price.

The mechanism is simple. The seller sets a „regular price” of 299 PLN and almost permanently displays it as crossed out. The current „promotional” price of 89 PLN looks like the deal of the century. Meanwhile, the price of 299 PLN has never been realistically charged or was charged for a very short period.

A banner „70% off today only” hanging for weeks is a marketing fiction. The Omnibus directive requires stating the lowest price from 30 days prior to the discount, so the discount is calculated from that lowest price, not from a fictitious „regular” price. UOKiK imposes fines of up to 10% of annual turnover for violations.

Other pricing tricks used in CBD

Scarcity (artificial shortage): „only 3 items in stock”, „ends in 2 hours”. This is a psychological urgency button that shortens reflection time. The actual stock level is often higher. UOKiK pursues practices of providing false information about availability.

Bundle pricing (artificial bundles): „buy 2 oils, the third for a penny”. The manufacturer inflates the price of a single product so that the bundle looks like a deal. When calculated per 1 mg of CBD, the bundle is often not cheaper than the competition's single version.

Decoy pricing (bait): three price variants where the middle one is „illogically” more expensive than the cheapest and slightly cheaper than the most expensive. The customer chooses the most expensive because it looks like the best value. An oil priced at 5%-10%-20% with prices of 79-179-219 PLN is a typical example.

Fake reviews: how to recognize fakes?

FTC (Federal Trade Commission) in 2023 introduced a ban on publishing fake reviews online, with a penalty of up to 50,000 USD for a single case (FTC, 2023). Nevertheless, the CBD market is full of review factories, especially on Amazon and smaller marketplaces. Polish stores are also not free from this practice.

Signs of a counterfeit are consistent. Extremely vague praises without dosage details („super product!”, „I recommend it to everyone!”). Identical phrases in many reviews across different platforms. No mention of adverse reactions, despite JAMA reporting drowsiness in 12% of CBD users in 2017.

Concentration of reviews in a short time is another red flag. If a store receives 50 five-star reviews in one day after months of silence, it is most often the purchase of a review package from a broker. Real reviews come in gradually and have varied lengths, styles, and structures.

Characteristics of an authentic CBD review

Authentic reviews indicate a specific dose („I started with 10 mg, now I take 25 mg in the evening”), duration of use („after 3 weeks I noticed”), comparison to other products („previously I had oil X from brand Y”) and mixed ratings („falling asleep has improved, but morning reflux remains”).

Pay attention to 3- and 4-star reviews. They are often more valuable than enthusiastic fives. They show real limitations of the product, suggest who it may not suit, and are less prone to being faked. Manufacturers do not buy packages of average reviews because they do not raise the average rating.

Check the reviewer's profile. Do they have other reviews? Are they from different categories? A reviewer who wrote 50 fives for different CBD stores in one week is most likely a bot farm.

Red flags when buying CBD: full list

The Polish Chief Sanitary Inspectorate recalled 14 CBD products from the market in 2024 for inconsistencies with the declared cannabinoid content or exceeding the THC limit (GIS, 2024). GIS data, FDA warning letters, and UOKiK decisions allow us to build a list of the 11 most common red flags when purchasing CBD.

Each of the following features does not necessarily indicate fraud on its own. But when several are combined, the likelihood that you are dealing with a low-quality product or even a scam increases sharply. Treat the list as a scoring system: 3+ flags = withdraw from the transaction.

List of 11 red flags

1. No COA for the current batch. The manufacturer shows an old certificate for all batches or none at all.
2. Promises of curing diseases. „Cures cancer”, „replaces antidepressants”, „treats epilepsy” – these are illegal health claims.
3. Eternal promotion of 70% off. A banner with a discount hangs for weeks, the base price is fictitious.
4. No type of extract on the label. It is unclear whether it is an isolate, broad spectrum, or full spectrum.
5. No data on the origin of the hemp. Country of cultivation, organic certification, strain – silence.
6. No extraction method. CO2, ethanol, oil maceration? The manufacturer does not inform.
7. No mg of CBD on the label. Only percentage, no conversion to milligrams.
8. Price per 1 mg below 0.05 PLN. Market anomaly, signal of an isolate or incorrect label.
9. Reviews concentrated in time. 50 fives in one day after months of silence.
10. Packaging pretending to be medicine. White-blue box with organ icons, slogans like drug leaflets.
11. No company data. No NIP, registered address, contact phone, return policy.

Always check points 1-7. Treat points 8-11 as additional signals. If you find 3 or more flags in one product, choose a competitor. The Polish CBD market is now developed enough that transparent brands are easily available.

What is worth paying more for in a CBD product?

EFSA in its scientific opinion from 2022 confirmed that the quality of the oil matrix and the purity of the raw material determine the safety profile of cannabinoids (EFSA, 2022). This is why an additional 30-50% for a truly quality product is a rational investment in safety, not a marketing whim.

The first element is CO2 extraction instead of ethanol. It yields a cleaner extract without the risk of solvent residues. The second issue is broad or full spectrum instead of isolate, meaning the entourage effect and a full terpene profile. The third thing is COA for each batch, not once a year.

The fourth factor is origin from certified EU farms. Poland, the Czech Republic, Lithuania, Estonia, and Germany have strict standards for pesticides and heavy metals. Raw materials from less regulated markets may be cheaper, but the risk of contamination is higher. Hemp is a bioaccumulative plant.

Table: cheap CBD vs good CBD

Feature	Cheap CBD	Good CBD
Price per 1 mg CBD	below 0.05 PLN	0.09-0.18 PLN
COA	none or old	current for each batch
Extract type	most often isolate	broad or full spectrum
Extraction	ethanol, maceration	supercritical CO2
Origin of hemp	unknown	EU, certified crops
Terpene profile	none or added flavor	natural, in COA
Mg CBD on the label	only percentage	percentage + milligrams + drops
Marketing	miracle promises, 70% off	education, facts, COA
Reviews	massive, general, concentrated	gradual, detailed, mixed

What is not worth the extra payment

Expensive marketing packaging, exclusive aluminum boxes, and celebrity campaigns can add 30-50% to the price without real product value. Limited „premium” editions often have the same COA as the standard line. You are paying for branding, not for substance.

Trendy additives in CBD oil like „with melatonin”, „with ashwagandha”, „with magnesium” usually contain trace amounts of these substances. For a clinical effect, you need 100-300 mg of ashwagandha, 200-400 mg of magnesium, 0.5-3 mg of melatonin. In a 10 ml oil, there is usually 1/10 of that dose, so it is more of a slogan than a real ingredient.

Marketing slogans like „ultra strong”, „x3 absorption”, „turbo formula” are not backed by evidence. Without a COA and data on nanoemulsion or liposomal formulation, „turbo” means nothing. Regular CO2 extraction in MCT yields 13-19% bioavailability, regardless of what the manufacturer calls their product.

Practical quality checklist before purchase

Before adding a CBD product to your cart, go through a list of 12 questions. Each „yes” increases the likelihood that you are buying a good product. Each „I don’t know” or „no” decreases that likelihood. Acceptance threshold: at least 9 out of 12 positive responses.

12 questions before purchase

1. Do I see the batch number on the packaging and COA for this specific batch?
2. Is the COA from an independent, accredited laboratory (ISO 17025)?
3. Does the COA list cannabinoids, terpenes, heavy metals, pesticides, and microorganisms?
4. Does the label provide milligrams of CBD in the package, not just the percentage?
5. Can I calculate the price per 1 mg of CBD, and does it fall within the range of 0.09-0.30 PLN?
6. Does the manufacturer specify the type of extract (isolate, broad spectrum, full spectrum)?
7. Is the extraction method known (preferably CO2)?
8. Is the country of origin of the hemp specified (preferably EU)?
9. Does the label contain the carrier oil (MCT or hemp seed oil) and CBD extract separately?
10. Does the product marketing avoid promises of curing diseases?
11. Are the product reviews varied, specific, and spread over time?
12. Does the store have clear company data: NIP, address, phone, return policy?

The list may seem strict, but good brands meet all 12 points without issue. Three or more „no” responses are a sign that it’s worth looking for an alternative. In Poland in 2026, you won’t have to compromise: transparent stores with COA certificates are easily available online and offline.

How to safely test a new CBD product?

Even a quality product should be introduced gradually. WHO in a review from 2018 assessed CBD as well-tolerated up to a dose of 1500 mg daily in adults, but noted individual differences in sensitivity (WHO, 2018). The protocol "start low, go slow" is the standard for cannabinoid supplements.

The principle is simple. Start with 5-10 mg of CBD daily for the first 3-7 days. Observe the reaction: sleep quality, stress level, any side effects (drowsiness, dry mouth, headaches, stomach issues). If everything is stable, increase to 15-20 mg.

After 2 weeks, assess the overall effect. CBD does not work like a tranquilizer with an immediate effect, but as a modulator of the endocannabinoid system, which reaches full activity after 2-4 weeks of regular use. Patience pays off.

When to consult a doctor?

CBD and CBG inhibit cytochrome P450 enzymes, mainly CYP3A4 and CYP2C9. This can affect the metabolism of many medications, including warfarin, statins, antiepileptics, and some antidepressants (PMC, 2019). Before combining CBD with medications, consult a doctor or pharmacist.

Consultation is especially important for individuals taking antiepileptics, anticoagulants, heart medications, medications for autoimmune diseases, antidepressants, and anxiolytics. During pregnancy, breastfeeding, and in children, CBD is not recommended without a doctor's indication due to the lack of long-term safety studies.

How to calculate dosing from milligrams to drops?

Project CBD in its 2023 dosing guide recommends a typical starting dose of 10-20 mg of CBD daily for an adult (Project CBD, 2023). Most oils have a dropper calibrated for drops, so you need to convert milligrams to the number of drops.

Standard conversion: 1 drop of 5% oil is about 2.5 mg of CBD, 10% oil is about 5 mg of CBD, 15% oil is about 7.5 mg of CBD, 20% oil is about 10 mg of CBD. A dose of 20 mg daily with 10% oil is 4 drops. Most 10 ml bottles contain 200 drops, which is enough for 50 days at a dose of 4 drops daily.

Sublingual dosing: hold drops under the tongue for 60-90 seconds before swallowing. This allows cannabinoids to be absorbed through the mucous membrane directly into the bloodstream, bypassing the first-pass effect through the liver. The bioavailability of this form reaches the upper limit of the range of 13-19%.

Legal and regulatory aspects 2026

The Polish CBD market operates at the intersection of several legal regimes. EFSA has been conducting a Novel Food procedure for CBD since 2019, which we expect to conclude in 2026-2027 (EFSA, 2022). Meanwhile, products are sold as cosmetics, dietary supplements in a gray regulatory area, and collectibles.

The THC limit in products from industrial hemp in Poland is 0.3% (Dz.U. 2005 nr 179 poz. 1485). Imported products must meet the Polish limit, regardless of origin. GIS regularly monitors the market and recalls non-compliant batches. UOKiK pursues unfair pricing and marketing practices.

Advertising CBD is subject to restrictions. Unauthorized health claims by EFSA cannot be used. The product cannot be presented as a medicine. It cannot be suggested that the supplement replaces pharmacological therapy. Violating these rules risks administrative penalties and product recall decisions.

A verified CBD store: what to pay attention to?

Choosing a seller is as important as choosing a product. A good store publishes COA for each batch, has clear company data with NIP and address, follows consumer law return policies, and offers substantive support. More about this, how to find a good CBD store, can be found in a separate guide.

Contact is an important test. Call or write a question about COA, raw material origin, extraction method. A store that responds specifically and within 24 hours is of a different quality than one that ignores messages or refers to a generic FAQ page. Substantive support is also a test of the team's knowledge.

An educational blog with sources and links to studies signals that the brand treats the customer as a partner in health decisions, not just as a consumer. Superficial marketing content or copied from competitors is a sign that priorities lie in sales, not education.

Alternative hemp forms

CBD oil is the standard, but not the only form. For those preferring tasty forms, alternatives are hemp jellies, capsules for convenient dosing, or dried hemp for those using vaporization. Regardless of the form, the quality criteria remain the same: COA, origin, extract, transparency.

Hemp shots and topicals (ointments, balms) work locally or are specially formulated. When choosing a CBD ointment for joint pain or flavored hemp shots, check the same parameters: type of extract, mg of CBD, COA, origin. The form differs, but the evaluation criteria remain constant.

If you are considering CBD in the context of chronic pain or a specific health issue, check out the separate material CBD and chronic pain: what science says and what marketing claims. There we discuss detailed dosing protocols and the limitations of current clinical research.

Frequently Asked Questions

Why is cheap CBD so suspicious in quality?

In the 2017 JAMA study conducted by Bonn-Miller, Loflin, and Russo from Penn State and ICCI, 69% of the 84 tested CBD products had labels inconsistent with the actual cannabinoid content (JAMA, 2017). Extremely low prices usually indicate savings on raw materials, CO2 extraction, and independent laboratory testing. Lack of COA for a given batch is the number one red flag.

How to calculate the true price per milligram of CBD?

Divide the price of the bottle by the number of milligrams of CBD in the package, not by percentages. A 10% oil in a 10 ml bottle contains about 1000 mg of CBD. The average cost of 1 mg in broad spectrum products with laboratory testing falls within the range of 0.09-0.18 PLN according to a review of the Polish market (Project CBD, 2023). Prices below 0.05 PLN per mg signal either an isolate or a label inconsistent with the content.

What is COA and what should it contain?

COA (Certificate of Analysis) is a report from an independent laboratory for a specific batch of the product. It should list: cannabinoid content (CBD, CBDA, CBG, THC), pesticide residues, heavy metals, mycotoxins, microorganisms, and solvents. The FDA in warning letters from 2015-2024 has indicated lack of COA as a frequent ground for legal action against CBD sellers (FDA, 2024).

What does an isolate masquerading as full spectrum mean?

It is a CBD isolate (purity over 99%) sold under the full spectrum label, even though it contains no additional cannabinoids or terpenes. Project CBD in its 2023 analysis indicated that about 30% of products labeled full spectrum in laboratory tests turned out to be isolates with added cannabis flavor (Project CBD, 2023). Without a cannabinoid list on the COA, one cannot distinguish between the two.

Is MCT as a carrier a scam?

No, if it is clearly declared on the label. MCT oil from coconut is a standard carrier for CBD because it improves oral bioavailability by 3-5 times compared to other fats (Frontiers in Pharmacology, 2020). The problem arises when the manufacturer hides the fact that the product is 95% MCT and only 5% extract, while simultaneously suggesting 1500 mg of CBD. This is pure manipulation of consumer expectations.

Why do stores use eternal promotions of 70% off?

This is an anchoring technique described by Tversky and Kahneman in 1974. Since 2023, UOKiK has been enforcing the Omnibus directive, which requires the lowest price from the 30 days prior to the promotion (Office of Competition and Consumer Protection, 2024). Nevertheless, many CBD sellers still inflate the base price. A banner of 70% off hanging for weeks is a sign that the catalog price is a marketing fiction.

How to recognize fake product reviews for CBD?

FTC in 2023 introduced a ban on publishing fake reviews, with a penalty of up to 50,000 USD for a single case (FTC, 2023). Signals of fakes include extremely general praises without dosage details, identical phrases in many reviews, lack of information on adverse reactions, and concentration of reviews in a short time. Authentic reviews indicate a specific dose, duration of use, and comparison to other products.

What are the biggest red flags when buying CBD?

No COA for the current batch, promises of curing specific diseases (cancer, epilepsy, depression), eternal promotions of 70% off, hiding the type of extract, lack of data on the origin of the hemp and extraction method. GIS recalled 14 CBD products from the Polish market in 2024 for inconsistencies with the declared cannabinoid content (GIS, 2024). These are the number one red flags according to Polish sanitary supervision.

What is worth paying more for in a CBD product?

For CO2 extraction instead of ethanol (lower risk of solvent residues), for broad or full spectrum instead of isolate (entourage effect), for COA for each batch, for origin from certified EU crops, and for clear declaration of mg of CBD and mg of other cannabinoids. EFSA in its 2022 opinion confirmed that the quality of the oil matrix and the purity of the raw material determine the safety profile (EFSA, 2022).

Does a high price guarantee high quality?

Not automatically. Expensive marketing packaging, exclusive boxes, and celebrity campaigns can add 30-50% to the price without real product value. What matters is the price-to-mg CBD ratio with confirmed quality. A review of the Polish market in 2024 showed that 5% oils in the range of 76-170 PLN achieve comparable COA results (Hemp Facts, 2024). The most expensive does not always mean the best.

Summary: informed choice over marketing

The debate between "cheap CBD or good CBD" can be resolved with three numbers and one document. The first number is the price per 1 mg of CBD, ideally in the range of 0.09-0.18 PLN. The second number is the declared milligrams of CBD on the packaging, not just the percentage. The third number is the THC limit below 0.3%. The document is the COA for the current batch.

The rest are consequences. A transparent manufacturer in pricing is also transparent about the origin of the raw material, extraction method, and laboratory results. A manufacturer hiding one element usually hides the others as well. JAMA, FDA, FTC, GIS, and UOKiK have shown that a low price is a weak predictor of quality, and a high price is not a guarantee of it.

If you are starting your journey with cannabinoids, choose a broad spectrum oil of 5% or 10% with a current COA, CO2 extraction, and a clear declaration of milligrams of CBD on the bottle. Start with 10-20 mg daily, observe the reaction for 2-4 weeks, adjust the dose. This is a simple principle that saves money and protects against marketing traps.

This article is for informational and educational purposes and does not constitute medical advice. Before starting to use CBD or other cannabinoids, consult a doctor, especially if you are taking medications, are pregnant, breastfeeding, or have chronic diseases. CBD may interact with medications metabolized by cytochrome P450 enzymes.

Author: Michał Waluk, Editor of the Bucha blog
Publication date: April 26, 2026
Next update: April 26, 2027